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Abstract 
Formulation and Evaluation of a Novel Irrigant for the Disinfection of Root Canals Using a 
Candida albicans Biofilm Model 
 
Dustin S. Reynolds, DDS 
 
An important goal of root canal therapy is elimination of microorganisms which are 
usually organized into a biofilm phenotype.  Irrigants play an indispensable role in areas 
inaccessible to mechanical instrumentation.  In this study, a novel endodontic irrigant was 
formulated composed of a penetrating solvent, 70% Dimethyl sulfoxide (DMSO), with a 1:1 
molar ratio of an antibiotic (Clindamycin HCl) and antifungal agent (Nystatin).  Nuclear 
Magnetic Resonance Spectroscopy (NMR) stability tests were conducted to prove the mixture 
was chemically stable.  This study compared different concentrations of the novel irrigant to 6% 
sodium hypochlorite (NaOCl) using a C. albicans biofilm model.  Furthermore, it is proposed 
that the novel irrigant has the ability to penetrate into dentin tubules and therefore be able to 
achieve better root canal disinfection. 
Solutions of the irrigant were prepared and used at 100%, 50%, and 25% concentration 
then compared to 6% NaOCl in the following tests:  ZOI, CFU, absorbance, coverage area, and 
penetration.  Standard zones of inhibition (ZOI) trials were conducted to verify that the novel 
irrigant was, in fact, effective against microorganisms.  C. albicans, a common oral fungi, and 
possible co-aggregate in biofilm formation, was then grown on hydroxyapatite-coated pegs 
(Calgary Biofilm Model) for 48 hours at 37° C and immersed in treatment solutions for one 
minute.  Biofilm was removed from the pegs via sonication and colony forming units per ml 
were assayed.  On additional pegs, biofilm was stained with crystal violet, washed, placed in 
glacial acetic acid and read at 562nm; the absorbance values reflected the amount of remaining 
biofilm.  On other pegs the remaining biofilm was stained and analyzed with computer software 
to determine the coverage area.  Lastly, ten extracted human teeth were prepared, sterilized, and 
irrigated using 6% NaOCl, Ethylenediaminetetraacetic acid (EDTA), and the novel irrigant at 
100%, 50%, and 25% concentration.  The teeth were then stained with Rhodamine B and viewed 
at 10X with a laser confocal microscope to evaluate penetration.   
The ZOI studies showed that the novel irrigant possessed effective anti-microbial 
properties.  The CFU assay positive control showed 2.9X10
6 
CFUs, the irrigant concentrations 
from greatest to least had the following CFUs respectively:  8.7X10
3
, 2.7X10
4
, and 6.7X10
3
.  No 
CFUs were observed with NaOCl; corresponding absorbance data revealed the following:  0.786, 
0.830, 0.818 compared to a control value of 0.765.  NaOCl had an absorbance of 0.843.  These 
numbers suggest similar activity against a recalcitrant C. albicans biofilm.  The biofilm coverage 
assay showed that the novel irrigant was more effective than 6% NaOCl.  By utilizing the laser 
confocal microscope the ability of the novel irrigant to penetrate into dentin tubules was 
visualized. 
Preliminary results using a C. albicans biofilm model show that all concentrations of the 
novel irrigant are anti-biofilm and demonstrate similar efficacy to that of 6% NaOCl.  
Furthermore, the novel irrigant is able to penetrate further into dentinal tubules than that of 6% 
NaOCl and EDTA or some combination of the two. 
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Chapter 1 
Introduction 
Even with the evolution of modern rotary instrumentation, various new sealers, and 
multiple obturation techniques there is no substitute for proper chemical disinfection and 
physical debridement of the root canal system.  Every health care professional has a disease to 
address, with endodontists treating pulpitis (inflammation of the pulp tissues) and apical 
periodontitis (inflammation and pathology associated with the apical tissues).  It has long been 
known that microorganisms are the main cause of periapical disease (Kakehashi 1965).  
Therefore, what is placed into the prepared root canal system for the purpose of obturation may 
not be as important as what is removed prior to placing a final seal.  One of the goals of effective 
root canal therapy (RCT) is the elimination of bacteria from the root canal system and the 
prevention of recontamination (Bystrom & Sundqvist 1981).  Endodontic therapy remains an 
effective means of stabilizing and preserving the natural dentition.  The rate of success versus 
failure of endodontic therapy completed at West Virginia University from 1959 to 1979 was 
evaluated and determined that success had been achieved in 89.66% of 1,770 canals (Swartz 
1983).  Other studies report success rates of up to 96% (Sjogren 1990).  Success rates of 
endodontic therapy are known to be better when teeth are free of bacteria after chemo-
mechanical instrumentation (Bystrom 1987, Sjogren 1997).  Under most clinical circumstances, 
endodontists are unable to create a sterile root canal environment, and the aim of treatment 
should be to effectively reduce the bio load in the root canal system and apical tissues by proper 
disinfection to a level where the body’s defenses and healing mechanisms are able to prevail.  
Proper instrumentation is undoubtedly an important component of effective RCT and provides 
for the removal of a significant amount of intra-radicular infected dentin.  Irrigants play an 
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indispensable role in areas inaccessible to instrumentation such as lateral and accessory canals, 
fins, and webs (Hasselgren 1988). 
The properties of an ideal endodontic irrigant include possessing an anti-bacterial effect, 
ability to dissolve organic and inorganic tissue, have a lubricating and flushing effect, not be 
toxic to surrounding tissue, and not weaken tooth structure (Haapasalo 2010).  Though there are 
currently numerous endodontic irrigants on the market, none of the presently available agents 
meet such requirements.  In this study, a new endodontic irrigant containing 70% Dimethyl 
sulfoxide and an approximate 1:1 molar ratio of Clindamycin HCl and Nystatin is evaluated.  
This new irrigant is compared to full strength (6%) NaOCl on the ability to eliminate known 
endodontic pathogens, including Candida albicans, from a cultured biofilm grown on 
hydroxyapatite coated plastic pegs (Calgary Biofilm Device).  The new irrigant is also compared 
to 6% NaOCl and 17% Ethylenediaminetetraacetic acid (EDTA) for its ability to penetrate into 
dentin tubules.  Laser confocal microscopy was used to visualize penetration into dentin tubules 
of extracted human teeth. 
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Statement of the Problem 
Will a novel endodontic irrigant composed of Clindamycin, Nystatin, and DMSO have the 
ability to penetrate into the dentin tubules and be anti-microbial against a Candida albicans 
biofilm phenotype as compared to full strength NaOCl?   
Significance of the Problem 
Although the success rate of non-surgical endodontic therapy is relatively high (92% success in 
cases without apical periodontitis and 74% in cases with apical periodontitis according to Phase 
One of the Toronto Study), it remains that if 24 million root canals are performed in the United 
States each year, there are 2 million failures of cases without apical periodontitis and 6 million 
failures of cases with apical periodontitis (Friedman 2003).  With the advent of modern rotary 
instrumentation we are able to better clean and shape the canal space; however, it is well known 
that the canal anatomy and dentin tubule structure may still harbor pathogens that can contribute 
to endodontic failure.  In a case study by Vieira et al., it was shown that a persistent intra-
radicular infection caused by bacteria located within dentinal tubules was the most reasonable 
explanation for resurgence of an apical periodontitis lesion (Vieira 2012).  These areas are only 
accessible by chemical debridement; therefore, if the success rate of non-surgical endodontic 
therapy is to be increased, an endodontic irrigant capable of addressing these areas inaccessible 
to mechanical debridement must be developed.   
Null Hypothesis 
There is no significant difference in the ability of the test solution to penetrate into dentin tubules 
and effectively eliminate a Candida albicans biofilm phenotype as compared to full strength 
NaOCl. 
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Assumptions 
1) NaOCl is the most commonly used irrigation material and thus chosen for comparison 
in this experiment. 
2) Passive irrigation with a 30ga ProRinse® (DENTSPLY) needle results in a clinically 
acceptable method of irrigation. 
3) No current irrigation materials meet the characteristics of an ideal irrigant. 
4) Incomplete or ineffective irrigation contributes to endodontic failure and apical 
periodontitis.   
5) A Calgary Biofilm Device study model is an appropriate method of evaluating 
irrigant effectiveness against a biofilm phenotype. 
6) Laser Confocal Microscopy is an effective way to visualize penetration into dentin 
tubules. 
Limitations 
1) An in vitro experiment is simulating an in vivo situation. 
2) There is a human element in performing all techniques. 
3) The plastic hydroxyapatite coated pegs may not accurately simulate biofilm formation 
in vivo. 
4) The root canals used will be similar, but will not have identical morphology. 
5) Individual root canal system variability could affect the instrumentation and irrigation 
of any given tooth. 
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Delimitations 
1) The extracted teeth were selected carefully in an attempt to minimize variability. 
2) Only single rooted anterior teeth were selected 
3) Teeth selected had completely formed apices  
4) Teeth were sectioned at the mid-root level to allow uniform sampling of penetration 
into the canal. 
5) All experimentation, instrumentation, and irrigation were performed by the principal 
investigator. 
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Chapter 2 
Review of Literature 
Sodium hypochlorite (NaOCl) in varying concentrations from 0.5% to 6% has long 
remained as the most commonly recommended irrigating solution utilized in RCT.  It was first 
recommended as an antiseptic solution by Dr. Henry Dakin (Dakin 1915).  In a recent survey by 
Dutner to members of the American Association of Endodontists (AAE), it was found that >90% 
of respondents used NaOCl as an irrigant (Dutner 2012).  NaOCl has strong antibacterial 
(Bystrom 1983) and tissue dissolving effects (Rosenfeld 1978), but is toxic to periapical tissue 
(Gernhardt 2004) and has been suggested to degrade micromechanical characteristics of dentin 
(Ari 2004).  In addition, NaOCl has no effect on the inorganic part of the smear layer 
(Baumgartner 1987).  Therefore 17% EDTA is used as part of some irrigation protocols after the 
use of NaOCl to remove the smear layer by chelation.  In 2011, Qian et al. showed that if NaOCl 
is used again after EDTA or citric acid as the final antibacterial rinse, it causes marked erosion of 
the root canal wall dentin (Qian 2011).  While NaOCl remains a part of the endodontic 
armamentarium, there continues to be some areas of debate and concern over its use. 
The subject of much discussion over the years has been which dilution of NaOCl is 
appropriate to use during endodontic irrigation.  In a case study by Cymbler and Ardakani, it was 
shown that the accidental injection of sodium hypochlorite into the periapical soft tissues can 
elicit a severe reaction including severe pain and a burning sensation (Cymbler 1994).  5.25% 
NaOCl has been used as an irrigant for at least seven decades (Walker 1936).  Shih’s tube 
dilution studies showed that NaOCl had germicidal activity against Str. faecalis and S. aureus, 
even at a dilution of 1:1,000; however, only full strength NaOCl had an apparent immediate 
sterilizing effect in root canals of extracted human teeth inoculated with Str. faecalis or S. aureus 
(Shih 1970).  A study performed by Hand et al. found that 5.25% NaOCl was significantly more 
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effective as a necrotic tissue solvent than 2.5% NaOCl, 1% NaOCl, 0.5% NaOCl, distilled water, 
normal saline solution, or 3% Hydrogen Peroxide (Hand 1978).  For many years the bulk of 
literature had turned its attention on NaOCl’s ability to dissolve necrotic tissue with no mention 
of its effect on vital tissue.   
Rosenfeld et al. performed a study to evaluate the solvent action of 5.25% NaOCl on vital 
human pulp tissue that had not been disturbed by instrumentation.  They found that in non-
confined areas, it is apparent that NaOCl has a strong, nonspecific, surface-acting solvent action 
on vital, intact, young, pulp tissue (Rosenfeld 1978).  Major problems have also been reported 
when 5.25% NaOCl is injected into human periapical tissue (Sabala 1989).  Because of these 
types of safety concerns, Spangberg et al. recommended 0.5% NaOCl for acceptably non-
cytotoxic levels (Spangberg 1973).  Baumgartner and Cuenin could not detect any difference in 
the removal of pulpal remnants and predentin in the middle third of root canals with 5.25%, 
2.5%, or 1% NaOCl delivered with either a needle or an ultrasonic device.  0.5% NaOCl left 
what appeared to be a few fibrils from predentin on the surface (Baumgartner 1992).   
Hand et al. stated that “the surface area of tissue exposed to the test solution is important 
because dissolution is a function of surface contact” (Hand 1978).  Koskinen et al. stressed the 
importance of good contact between tissue and irrigant (Koskinen 1980).  Palazzi et al. 
concluded that the new 5.25% NaOCl solutions modified with surfactants, Hypoclean A and 
Hypoclean B, had surface tension values that were significantly lower than Chlor-Xtra™ and 
5.25% NaOCl.  It was also reported that these new irrigants have the potential to both penetrate 
more readily into un-instrumented areas of the root canal system and also allow a more rapid 
exchange with fresh solution enabling greater antimicrobial effectiveness and enhanced pulp 
tissue dissolution ability (Palazzi 2012).  Baker et al. concluded that “the removal of micro-
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organisms and debris seemed to be a function of the quantity rather than the type of irrigant” 
(Baker 1975).  Moorer et al. found that an excess of organic matter rapidly depletes the activity 
of NaOCl and also lowers the pH drastically during the first moments of the reaction (Moorer 
1982).  Moorer concluded that “the amount of available chlorine in a hypochlorite system is 
important, not the mere initial strength of the hypochlorite solution.  The recommended strength 
of antibacterial NaOCl is dependent on the amount of organic substances that are present.  It can 
be safely stated that any hypochlorite solution that is able to dissolve tissue is, at the same time, a 
powerful disinfectant” (Moorer 1982).  Baumgartner also concluded that “the effectiveness of 
low concentrations of NaOCl may be improved by using larger volumes of irrigant, by frequent 
exchange of irrigant, or by the presence of replenished irrigant in the canals for longer periods of 
time” (Baumgartner 1992).  Senia et al. found that full strength NaOCl did not appear to be very 
effective in removing pulp tissue which remained after instrumentation.  Furthermore, without 
direct contact with NaOCl, the deeper protected tissues were dissolved more slowly and less 
completely (Senia 1971).  Any tissue that remains after instrumentation and in deeper areas may 
harbor additional bacteria that could lead to endodontic failure. 
MTAD
®
 (DENTSPLY) is a mixture of 3% doxycycline, 4.25% citric acid, and a 
detergent (Tween 80).  It was introduced in 2003 by Torabinejad and Johnson at the Loma Linda 
University as an endodontic irrigant to address some of the short comings of NaOCl and other 
endodontic irrigants.  It is considered to be a clinically effective, biocompatible endodontic 
irrigant (Zhang 2003).  Ring et al. concluded that the cytotoxicity of NaOCl/MTAD
®
 was found 
to be slightly less than NaOCl and NaOCl/EDTA, indicating that MTAD
®
 is more biocompatible 
than NaOCl (Ring 2008).  This finding may prove beneficial as we move toward more pulp 
regenerative techniques in endodontics.  Doxycycline, being MTAD
®’s antibacterial agent, is a 
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bacteriostatic antibiotic and does not kill bacteria; it prevents the multiplication of susceptible 
bacteria.  It can be assumed that residual bacteria may resume growth when appropriate 
conditions are restored and may cause reinfection (Singla 2011).  Early in-vitro studies by 
Torabinejad showed that MTAD
®
 demonstrated superior ability in killing E. faecalis and exerted 
better anti-bacterial properties at high dilutions than did NaOCl (Torabinejad 2003).  Later 
research however, has shown that MTAD
®
 may not exhibit optimal antimicrobial properties.  In 
a study by Kho and Baumgartner, it was shown that there was no difference in the antimicrobial 
efficacy for irrigation with 5.25% NaOCl and 15% EDTA versus irrigation with 1.3% NaOCl 
and MTAD
®
 in the apical 5mm of roots infected with E. faecalis (Kho 2006).  Dunavant found 
that NaOCl was significantly more efficient in elimination E. faecalis biofilms than MTAD
®
 
(Dunavant 2006).  In a study performed by Johal et al., no growth of E. faecalis was found in 
root canals irrigated with 5.25% NaOCl and 15% EDTA, while 50% of canals irrigated with 
1.3% NaOCl and MTAD
®
 demonstrated growth of E. faecalis (Johal 2007).  Giardino et al. 
showed that only 5.25% NaOCl could disaggregate and remove the E. faecalis biofilm each time 
when compared to MTAD
®
 and other endodontic irrigants (Giardino 2007).  In regard to anti-
fungal activity, Ruff et al. showed that 6% NaOCl and 2% chlorhexidine independently were 
equally effective and superior to MTAD
®
 and 17% EDTA independently (Ruff 2006).  De-Deus 
et al. reported significantly faster dissolution of inorganic material by both 5% citric acid and 
MTAD
®
 as compared with 17% EDTA (De-Deus 2007).  Also, MTAD
®
 has been shown to 
solubilize pulpal tissue (Beltz 2003).  MTAD
®
 has made its mark on endodontics as an adjunct to 
the current irrigation protocol, but some of its antibacterial efficacy has come into question, 
leading to the pursuit of several possibilities of alternative irrigants.  In addition, as is the case 
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with many endodontic products, MTAD
®’s use has been hindered by its relatively high cost and 
difficult handling and storage characteristics.   
QMiX™ (DENTSPLY) is an endodontic irrigant that possesses antimicrobial effects with 
the added ability to remove the smear layer in one ready to use solution.  QMiX™ contains 
EDTA, chlorhexidine (CHX) and a detergent.  Mixing EDTA and CHX is known to produce a 
white precipitate (Rasimick 2008).  There has also been concern that mixing NaOCl and CHX 
produces a brown/orange precipitate that could potentially be carcinogenic.  Despite the CHX 
content, mixing QMiX™ with NaOCl does not produce any precipitate and the solution does not 
change color (Stojicic 2012).  The antimicrobial agent in QMiX™, CHX, is a chemical antiseptic 
with activity against both gram positive and gram negative organisms.  It exerts both 
bacteriostatic and bactericidal effects.  CHX is found in many dental applications as well as some 
topical preparations.  CHX is deactivated by anionic compounds commonly used as surfactants 
in detergents (Denton 2001).  In a study by Stojicic et al. it was concluded that QMiX™ and 
NaOCl were superior to CHX and MTAD
®
 under laboratory conditions in killing E. faecalis and 
plaque bacteria in planktonic and biofilm culture (Stojicic 2012).  Ma et al. concluded that 
QMiX™ was equally effective in killing bacteria in dentin as 6% NaOCl (Ma 2011).  In a study 
by Ordinola-Zapata et al. comparing 1% NaOCl, 2% CHX, 10% citric acid, 17% EDTA, and 
distilled water, only 1% NaOCl had a significant effect on biofilm viability and architecture 
(Ordinola-Zapata 2012).  Mohammadi and Abbott conclude that CHX is an effective antifungal 
agent, but its efficacy is significantly less than NaOCl (Mohammadi 2009).  The ability of 
QMiX™ to remove the smear layer is comparable to EDTA (Stojicic 2012).  Because CHX does 
not have the ability to dissolve tissue, QMiX™ is recommended as a final rinse after NaOCl.  
Dai et al. concluded that the two experimental versions of QMiX™ used in the open canal 
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designed experiment were as effective as 17% EDTA in removing canal wall smear layers after 
the use of 5.25% NaOCl as the initial rinse (Dai 2011).  While QMiX™ is another addition to the 
endodontic irrigation protocol there are still some shortcomings of its use as a lone irrigant and 
inability to dissolve tissue. 
Dimethyl sulfoxide (DMSO) was first synthesized by Alexander Saytzeff in 1867 by the 
oxidation of dimethyl sulfide (Saytzeff 1867).  DMSO is basically a by-product of a process 
known as kraft pulping, in which wood is turned into wood pulp for many paper making 
applications.  Lignin is the source of DMSO and wood contains approximately 25-30% lignin.  
In 1962, Crown Zellerbach obtained a patent for the processing of this by-product, which utilized 
the methyl groups of kraft lignin by adding molten sulfur to form dimethyl sulfide.  Nitrogen 
tetroxide was then used to oxidize the dimethyl sulfide to dimethyl sulfoxide (Herschler 1965).  
Several peculiar chemical and therapeutic properties of DMSO were soon discovered when Dr. 
Stanley Jacob began seeking a relatively pure solution of DMSO for use as a cryostatic agent to 
protect organ transplants against freezing damage while in storage (David 1972).  Perhaps the 
most fascinating characteristic of DMSO is its ability to penetrate living tissues without causing 
significant damage.  This is related to its relatively compact structure and polar nature as well as 
its capacity to accept hydrogen bonds.  Dr. Stanley Jacob at the University of Oregon Medical 
School then began a series of experiments to show that DMSO was an active penetrant and 
carrier of other substances through the skin or tissue membranes.  Initial studies showed that 
DMSO enhanced the absorption of heparin, insulin, sodium salicylate, Evans Blue dye, 
sulfadiazine, aminophylline, and thio TEPA through the intact urinary bladder of the dog (Jacob 
1964).  DMSO is classified as a dipolar, aprotic hydroscopic solvent that appears pyramidal in 
shape or like a tetrahedron with the sulfur atom in the center and the two methyl groups, the 
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oxygen atom, and a nonbonding electron pair located at the apices (David 1972).  The ability of 
DMSO to penetrate skin and mucous membranes may be the result of its dynamic interaction 
with tissue water (Szmant 1971).  “The alteration in the configuration of immobile protein 
structures brought about by DMSO exchanging sites with bound water molecules may explain 
the penetration of DMSO through the skin.  The transfer of DMSO across the dermal barrier is 
accomplished rapidly and completely without irreversible tissue damage and the alterations in 
protein structure are reversible” (David 1972).  There have been numerous animal studies to 
confirm the membrane penetrability of DMSO.  McDermot, Murray & Heggie investigated the 
percutaneous penetrability and drug carrier potentials of DMSO in guinea pigs and rabbits.  They 
detected longer plasma duration of 1-methyl-2-hydroximinomethylpyridium methane sulfonate 
(P2S) when it was added to DMSO and applied topically versus intramuscular injection.  This 
was attributed to the slow continuous passage of the compound through the skin or by DMSO 
interfering in some way with the metabolism or excretion of P2S (McDermot 1965).  Hucker et 
al. found maximum serum levels of DMSO 4 to 8 hours after dermal administration; these levels 
then declined and 36-48 hours after application no DMSO was detected (Hucker 1967).  
Kligman obtained the fastest and greatest penetrability of dyes, corticosteroids, and other 
pharmacological agents through skin with 70-90% DMSO (Kligman 1965 Part I).  Chronic 
toxicity studies have been made for a number of routes of administration using various 
concentrations of DMSO.  Dermal application of 100% DMSO to backs of guinea pigs in 28 
daily applications and to hairless mice given two applications a week for 30 weeks caused no 
skin irritation and no toxicity (Smith 1967).  Kumar et al. showed that DMSO and Ethanol acted 
as a penetration enhancer for the transdermal delivery of Acyclovir and skin flux of the drug 
could be enhanced up to 107 fold compared to its aqueous solution (Kumar 2011).  In addition to 
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being able to penetrate human membranes and potentially carry other compounds with it, some 
have found that DMSO exerts anti-inflammatory and pain relief ability on its own.  “Pain relief 
from dermal administration of DMSO to affected areas seems to involve more than local 
analgesia, anti-inflammatory action, or vasodilation.  Cutaneous application of DMSO at some 
distance from the affected site usually relieves pain and inflammation in the latter location, 
suggesting that DMSO either has been carried by the circulation to the affected area to act locally 
or has depressed the central nervous system pain centers or both” (David 1972).  Ramirez & 
Luza gave intramuscular injections of 5ml of 80% DMSO two or three times a day to 42 severely 
disturbed psychiatric patients.  They felt that DMSO had antipsychotic and antianxiety properties 
and that its action differed from tranquilizers in that little sedation or central depression was 
produced (Ramirez 1967).    It was shown in a study by Formanek & Kovac that DMSO 
increased the infiltration of leukocytes into the traumatized area of cotton pellet implantation and 
suggested that the decreased formation of granulation tissue is due to an anti-inflammatory 
action (Formanek 1966).  Kligman observed that DMSO possesses potent histamine-like 
properties at the site of cutaneous application, resulting in an increased blood flow to the skin 
(Kligman 1965 Part I).  DMSO has even been shown to have antibacterial properties of its own.  
Jacob et al. found 20% DMSO bacteriostatic against E. coli, Staph. aureus, Pseudomonas, and in 
5% concentration, against the tubercle bacillus (Jacob 1964).  Kligman found DMSO a weak 
antifungal agent, which might be more effective when topical fungicides are incorporated in it 
(Kligman 1965 Part II).  Jacob reported on studies that indicated pretreatment of tubercle bacilli 
resistant to 2000 micro grams of streptomycin or isoniazid with 0.5-5% DMSO rendered this 
organism sensitive to 10 micro grams of either drug (Jacob & Wood 1967, Jacob 1971).  Kamiya 
et al added 5% DMSO to culture media, which restored the sensitivity of antibiotic-resistant 
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strains of bacteria to antibiotics and increased the sensitivity of those strains already sensitive to 
these agents.  For example, DMSO restored the sensitivity of Pseudomonas to colistin.  In 
addition, growth of E. coli, which is not affected by penicillin, showed growth-inhibitory effects 
when 5% DMSO was added to the culture (Kamiya 1966).  Significant amounts of 
methylmethanthiosulfinate was identified in DMSO treated bacterial cultures by Tsuchiya, 
Iriyama, & Umezawa, which they believe contributed to the antibacterial effect of DMSO 
(Tsuchiya 1964).  Gillchriest & Nelson believe DMSO may interfere with bacterial growth by 
altering the RNA conformational structure required for protein synthesis (Gillchriest 1969).  In 
an article by Rosenbaum, continued dermal application of DMSO in patients with postoperative 
or posttraumatic intractable pain, post-amputation phantom pain, and tic douloureux resulted in 
marked pain relief in 32 of 37 patients (Rosenbaum 1965).  Jacob found that over 75% of 
patients in a 60 patient study obtained relief of headache secondary to trigeminal neuralgia, 
sinusitis, cervical osteoarthritis, and temporal arteritis, when about 10-15ml of 50% DMSO were 
applied twice daily to the skin of the face and neck (Jacob 1965). 
Clindamycin has long been used to treat odontogenic infections of endodontic origin.  
Clindamycin reversibly binds to 50S ribosomal subunits preventing peptide bond formation thus 
inhibiting bacterial protein synthesis.  It is bacteriostatic or bactericidal depending on the drug 
concentration, infection site, and organism.  Clindamycin is metabolized in the liver where 
clindamycin phosphate is converted to clindamycin HCl (active).  Clindamycin is excreted in the 
urine (10%) and feces (4%) as active drug and metabolites.  Clindamycin is a pregnancy risk 
factor category B meaning adverse events were not observed in animal reproduction studies. 
Clindamycin crosses the placenta throughout pregnancy and at term, but use during pregnancy 
has not been shown to cause adverse fetal effects. Clindamycin pharmacokinetics are not 
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affected by pregnancy.  Small amounts of clindamycin transfer to human milk. The manufacturer 
does not recommend the use of clindamycin during breast-feeding.  Clindamycin has not been 
shown to interfere with oral contraceptive activity; however, it reduces GI micro-flora, thus, oral 
contraceptive users should be advised to use additional methods of birth control. About 1% of 
clindamycin users develop pseudomembranous colitis.  Prolonged use may result in fungal or 
bacterial super-infection, including C. difficile-associated diarrhea (CDAD) and 
pseudomembranous colitis; CDAD has been observed >2 months post-antibiotic treatment. 
Nystatin binds to sterols in fungal cell membrane, changing the cell wall permeability 
allowing for leakage of cellular contents.  Nystatin is excreted in the feces.  It is a pregnancy 
category risk factor C.  Animal reproduction studies have not been conducted. Adverse events in 
the fetus or newborn have not been reported following maternal use of vaginal nystatin during 
pregnancy. Absorption following oral use is poor.  Excretion into breast milk is not known.  The 
biological activity of polyene antibiotics (PA's), like Nystatin, sharply increases after their 
dissolution in DMSO and they are tenfold more efficient than their water-solved forms.  DMSO 
is the main solvent of membranoactive polyene antibiotics such as nystatin (Ibrajimova 2004). 
The polymorphic fungus Candida albicans is a member of the normal human micro 
biome.  In most individuals, C. albicans resides as a lifelong, harmless commensal.  Under 
certain circumstances, however, C. albicans can cause infections that range from superficial 
infections of the skin to life-threatening systemic infections.  Candida now ranks as the fourth 
most frequently encountered microbe among nosocomial bloodstream pathogens (Pfaller 1998).  
Several factors and activities have been identified which contribute to the pathogenic potential of 
this fungus.  Among them are molecules which mediate adhesion to and invasion into host cells, 
the secretion of hydrolases, the yeast-to-hypha transition, contact sensing and thigmotropism, 
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biofilm formation, phenotypic switching and a range of fitness attributes (Mayer 2013).  C. 
albicans may be the universal co-aggregate of endodontic biofilm formation.  In a study by 
Baumgartner et al. the presence of C. albicans was detected in 21% of samples taken from root 
canals (Baumgartner 2000).  C. albicans, a normal commensal of human mucosal surfaces and 
opportunistic pathogen in immunocompromised patients, is most frequently associated with 
biofilm formation.  Colonization of C. albicans allows the development of adherent biofilm 
structures from which cells can then detach and cause an acute fungemia and/or disseminated 
infection (Ramage 2012).  Microbiologists have historically studied planktonic organisms (free 
floating and homogeneous cells) in pure culture.  However, there has been a paradigm shift as 
the link between sessile (surface attached and heterogeneous cells) and microbial pathogenesis 
and human infection is now widely accepted (Costerton 1995).  Estimates suggest that up to 80% 
of all microorganisms in the environment exist in biofilm communities (Donlan 2002).  A 
growing body of knowledge suggests that organisms in biofilms assume a stronger pathogenic 
potential than those in a planktonic state (Svensater 2004).  “Biofilms are defined as highly 
structured communities of microorganisms that are either surface associated or attached to one 
another and are enclosed within a self-produced protective extracellular matrix (ECM).  Biofilm 
formation includes protection from the environment, resistance of physical and chemical stress, 
metabolic cooperation, and a community-based regulation of gene expression.  There has been 
an increased appreciation of the role that fungal biofilms play in human disease as microbes 
growing within biofilms exhibit unique phenotypic characteristics compared to their planktonic 
counterpart cells, particularly increased resistance to antimicrobial agents” (Ramage 2009).  
Glycoproteins and proteins supplied by saliva or gingival crevicular fluid act as the primary 
source of nutrients for the microbial communities of dental biofilms (Beighton 1986). 
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Chapter 3 
Materials and Methods 
Formulation of Novel Irrigant:   
Chemically pure samples of Clindamycin HCl (Lot # 021M1533V) and Nystatin (Lot # 
110M8715V) were purchased through Sigma Aldrich (Milwaukee, WI).  DMSO was obtained 
through Jacob Laboratories (Portland, OR) in 70% concentration.  An approximate 1:1 molar 
ratio of the two substances was dissolved in the DMSO (1mg Nystatin, 0.425mg Clindamycin 
HCL, 0.75mL of 70% aqueous DMSO [1.08mM or 0.1%wt.]).  NMR spectroscopy was 
performed to ensure stability of the new mixture.   
There was a concern that Clindamycin HCl may not be stable in the presence of Nystatin.  
Clindamycin is an alkyl chloride and Nystatin contains a primary amine.  Thus, alkylation of the 
amine portion of Nystatin to form the Clindamycin-Nystatin adduct (Figure 1) is possible.  While 
alkyl chlorides are often of low reactivity, alkylation reactions of the type shown in figure 1 can 
occur in DMSO and solvents containing a preponderance of DMSO.  This possibility was 
examined using NMR.   
The experiment required proton NMR data be acquired on samples of Clindamycin HCl, 
Nystatin, and a 1:1 mixture of the two.  If no reaction occurred, the spectrum of the 1:1 mixture 
should be comprised of the sum of the two spectra.  However, if a reaction occurred, significant 
changes in chemical shift of some of the protons are expected.  Chemical shift is dependent upon 
the attached functional groups.  Upon going from Clindamycin to the Clindamycin-Nystatin 
adduct, the chlorine is replaced by a nitrogen.  Protons adjacent to a chlorine appear at below 
3.44 ppm (below 3.44 means at numeric values greater than 3.44 ppm or protons adjacent to a 
chlorine are expected to appear downfield of 3.44 ppm and there is a shift expected due to the 
beta amino group to move it further downfield).  If the chlorine were replaced by an amino 
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group, an up-field shift is expected and the same proton would be expect to appear above 3 ppm 
(i.e., numerically, less than 3 ppm). 
 
 
 
 
 
 
 
 
 
 
 
 
Clindamycin HCl, Nystatin, D2O, and dmso-d6 were obtained from Aldrich (Milwaukee, 
WI).  All materials were used as received.  Samples containing Nystatin were protected from 
light. Nuclear Magnetic Resonance (NMR) spectra were recorded on a Varian Inova 
spectrometer operating at 600 MHz.  NMR tubes were obtained from Wilmad Glass (Vineland, 
NJ).  NMR assignments were made using a combination of TOCSY spectra, selective decoupling 
experiments, chemical shift and coupling information obtained from the NMR spectra.  The 
assignments were in general agreement with literature values for clindamycin (Verdier 2000) and 
nystatin (Bruheim 2004) though the literature values were obtained in solvents other than 
D2O/dmso-d6. 
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Figure 1:  Clindamycin-Nystatin Adduct 
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Stock solutions for NMR studies of Clindamycin HCl and Nystatin were prepared in a 
mixture of D2O and dmso-d6 (3:7) at a concentration of 1 mM.  Samples that only contained 
Clindamycin HCl or Nystatin were prepared by mixing the stock solution (0.5 mL) and then 
diluting with D2O and dmso-d6 (3:7) (0.5 mL).  The Clindamycin HCl/Nystatin sample was 
prepared by mixing equal amounts of the Clindamycin HCl and Nystatin stock solutions.  Once 
prepared, the NMR samples were maintained at 25
o
 C. 
Formulation of novel irrigant bulk sample:   
A sterile spatula was used to remove Clindamycin and Nystatin from their original containers 
which had been stored out of sunlight at 0 degrees Fahrenheit in a commercial freezer.  Sterile 
pipets were used to remove the 70% DMSO from its stock container.  In a weight boat on a 
digital scale, the following was measured .0212g Nystatin, .0108g Clindamycin, 15mL 70% 
aqueous DMSO.  The powder contents were carefully emptied into a 20mL screw top vial 
carefully using the 70% DMSO to wash the powder residue from the weigh boat into the vial.  
The remaining necessary 70% DMSO was added and the mixture was vortexed until all particles 
were dissolved.  The sample was stored in a commercial refrigerator at two degrees Celsius and 
the vial containing the novel irrigant was covered with aluminum foil to protect from sunlight. 
Cultivation of micro-organisms: 
Blood agar plates were streaked with stock samples of the following bacteria: 
Escherichia coli 
Pseudomonas aeruginosa 
Staphylococcus aureus 
Candida albicans 
Lactobacillus 
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These five organisms were chosen to be used in preliminary screening trials.  Based on the ease 
of growth, bi-phasic nature, and response to initial trials, C. albicans, was targeted for further 
study.  The plates were placed in an incubator at 37 degrees Celsius for 24 hours.   
ZOI Measurement (Biofilm and Planktonic Phenotype): 
A 1 uL loop of bacteria was taken from the blood agar plates and then placed into 5 mL of 
Tryptic Soy Broth (TSB) in a test tube.  The test tube was vortexed to ensure mixture of contents.  
250 uL of bacteria-containing TSB was plated onto a 30% poloxamer (nonionic tri-block of 
copolymers composed of a central hydrophobic chain of polyoxpropylene flanked by two 
hydrophilic chains of polyoxyethylene) plate (from stock poloxamer that had been poured and 
allowed to reach room temperature in order to firm).  An additional bacterial sample was also 
placed on stock Mueller-Hinton (Planktonic) agar plates.  The liquid was spread with an L-
spreader.  Blank discs (designed to hold a specific amount of treatment solution) were allowed to 
soak in each solution for 10 seconds and then they were wicked on a paper towel and placed onto 
the inoculum of bacteria.  See figure 10.  The plates were placed into an incubator (at 37°C) for 
24 hours.  After 24 hours, the plates were removed and ZOIs were recorded for each treatment 
type.  ZOIs were measured in mm with a digital micrometer.  Plates were then placed back into 
the incubator and ZOIs were again recorded at 48hrs. 
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Figure 2:  Blood Agar Plate inoculated with C. albicans 
 
 
 
Figure 3:  TSB culture media 
 
 
 
 
Figure 4:  Digital Micrometer 
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Figure 5:  Inoculated TSB 
 
 
 
Figure 6:  L-spreaders, micropipette, disposable inoculation loops and forceps 
 
 
 
 
Figure 7:  C. albicans ZOI plates Poloxamer (Biofilm)* 
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Figure 8:  C. albicans ZOI Mueller-Hinton Plates (Planktonic)* 
 
 
   
 
Figure 9:  S. aureus, P. aeruginosa, E. coli ZOI plates* 
 
*Note that these photos differ slightly from the template that appears on the next page because 
two anti-biotic discs were used (ATM- Aztreonam & LVX- Levofloxacin) on either side of the 
NaOCl; these results were not included because the ZOIs were overtaken by NaOCl and 
unreliable.  A blank disc was also soaked in PerioSheild
TM
 (located between the two blank 
control discs); these results were also not included. 
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Figure 5:  ZOI Diagram (Biofilm and Planktonic) 30% Poloxamer and Mueller-Hinton 
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Creation of Bacteria Biofilm on Hydroxyapatite-Coated Pegs (Calgary Biofilm Device): 
Candida albicans was chosen as the test organism.  A 10 uL loop was filled with the sample of 
C. albicans and placed into 40 mL TSB in a test tube.  The loop was swirled to ensure all 
contents had been released from the loop into the solution.  The test tube was vortexed to ensure 
even mixing.  An Innovotech microtider tray was filled with 200 mL of C. albicans-containing 
TSB into each well (perimeter wells were excluded to eliminate the chance of evaporation during 
incubation period).  The hydroxyapatite-coated pegs were placed into the microtider tray of C. 
albicans-containing TSB and allowed to incubate (37°C) for 48 hours (on a rocker set to 3.5 
rpm).  Rocking helped to ensure even biofilm formation on each of the hydroxyapatite- coated 
pegs. 
Treatment of Pegs with Cleansing Solutions: 
Once the incubation period was complete, two more microtider trays were filled.  The first tray 
was filled with treatment solutions (100%, 50%, 25% concentration of Novel Irrigant as well as 
70% DMSO and Full strength 6% NaOCl).  See figure 13.  The dilutions were made with sterile 
physiologic saline solution.  The second tray was filled with saline solution (for a wash).  The 
biofilm coated pegs were placed into the treatment solutions for 1 minute.  The biofilm coated 
pegs were then placed into the saline solution to wash for 1 minute.  The one minute in saline 
reflects the rinsing and drying of a root canal space and deactivation of the treatment solution. 
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Figure 6:  Photo of Calgary Biofilm Device 
 
 
Figure 7:  Diagram of Eukaryotic Yeast Cell Membrane (Courtesy of Dr. John G. Thomas) 
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Figure 8:  Diagram of Calgary Biofilm Device and assay template 
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Collection of CFU Data: 
A pair of sterile needle-nose pliers was used to break off pegs and place them into test tubes 
containing 4 mL saline.  Care was used to ensure that pegs treated with each treatment solution 
were collected separately and the needle-nose pliers were disinfected with a 70% ethyl alcohol 
rinse followed by de-ionized water and allowed to dry between samples.  Positive control pegs 
(no treatment) were also collected.  The test tubes were sonicated in a water bath set at 37°C for 
30 seconds.  Sonicating the tooth in saline ensures that all of the biofilm bacteria are extracted 
from the tooth surface and come off in solution.  A series of three  1 in 10 dilutions were made 
from each of the sonicated test tubes (sterile saline was used for dilution) and 250 uL of solution 
from each individual dilution was plated onto a Mueller-Hinton agar plate.  Mueller-Hinton 
plates were placed into the incubator (at 37°C) for 24 hours.  A colony-count of each plate was 
performed using aCOLyte software.  CFU (colony forming units) were calculated based upon the 
dilutions that were performed in order to reflect the actual number of bacteria that were present 
on the peg surface after it was treated with each solution. 
 
Figure 9:  Images of CFU assay plates 
 29 
 
Measurement of Optical Density: 
Needle-nose pliers were again utilized to break off tooth pegs (cleaning the pliers with alcohol 
wipes in between usages, but they were allowed to dry completely in between as well to avoid 
removal of the biofilm).  The pegs were placed into 2 mL of Crystal Violet for 15 min (tooth was 
completely coated in Crystal Violet to be used as a stain).  Pegs were removed from Crystal 
Violet and placed into 2mL of de-ionized H2O to wash for 1 min.  Pegs were placed into 2 mL 
glacial acetic acid (at 100% strength) to remove biofilm for 15 minutes.  Absorbance of solution 
was recorded at 562 nm. 
SEM Photography: 
Pegs were placed into vials of 10% neutral buffered formalin to preserve the biofilm formation.  
Pegs were photographed by SEM to ensure the presence of biofilm.  Consistent orientation was 
attempted by capturing the apical 1/3 of the pegs.  The samples were held down with carbon tape 
and a strip of copper tape was put over top of them. They were then coated with a gold palladium 
alloy. The thickness of the coating was between 5-10 nm.  The samples were tall and round, so 
the copper tape makes a circuit with the gold palladium coating.  The instrument used was a 
Hitachi S-4700 FE-SEM with an EDAX brand EDS detector in the WVU Department of 
Chemical Engineering, Benjamin M. Statler College of Engineering and Mineral Resources. All 
samples were run at 5.0 kV and a working distance of 10.5 mm. These numbers are included in 
the images. SE(M) means both upper and lower detectors were used (mixed), SE(L) means just 
the lower, and SE(U) means the upper detector was used. The lower detector is better for 
samples that charge or samples that have a lot of topography. The upper detector provides a 
clearer image in general, but doesn't show as much of the three dimensional features of the 
sample. Think of it as lighting a sample from above and looking down on it (upper detector) and 
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lighting a sample from the side and looking at it (lower detector). The mixed detector averages 
the two images together.  Biofilm Images were identified and staged according to the following 
table. 
Planktonic / Biofilm Staging 
Staging Description Characteristics 
0 Free Floating Individual Cells 
I A,B Early Loose, open 
II Immature/Moderate Increased biomass 
III Mature/Highly Complex Increased biodiversity 
IV A,B Late/Apoptosis or Necrosis Free-floating 
 
Figure 10:  Planktonic/Biofilm Staging Diagram 
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Figure 11:  Biofilm formation (Courtesy of Dr. John G. Thomas) 
 
Microscopy, Photography, and Biofilm Coverage Ranking Determination: 
Additional pegs were stained in crystal violet for 30 seconds.  Pegs were placed on microscope 
slides in emersion oil and viewed at 5X magnification via Zeiss microscope.  Representative 
photographs were taken.  Determination of biofilm coverage was performed by computer 
analysis using Image J software.  Appropriate information was obtained to set the scale of 
measurement.  An 8-bit reproduction of the original image was created.  The threshold value of 
pixels was adjusted to gain representation of the area of biofilm coverage.  The computer 
software then generated an outline image of the area covered including any holes in the selected 
area and measurement was made.  An average area was obtained and statistically analyzed.   
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Laser Confocal Microscopy Protocol: 
Extracted human single rooted anterior teeth were obtained from a local private dental practice 
which had been extracted as part of a normal dental treatment plan within the last 12months.  
The teeth had been stored in full strength NaOCl, glycerin, and distilled H2O.  The teeth were 
accessed with sterile 330 and Endo-Z burs in a high speed air-driven handpiece under high speed 
evacuation and water spray.  The teeth were then instrumented to length with EndoSequence
®
 
(Brassler) #40/06 rotary files at 550rpm.  Sterile H20 was used for lubrication and the procedure 
was performed on a bench top in the operator’s hand.  The prepared teeth were radiographed, 
placed in a plastic container of sterile water (provided by WVU SOD central dispensing and 
sterilization department), and were then autoclaved.  A jig was created with PVS heavy body 
putty (3M ESPE) to be used as a mold so that blue acrylic custom tray material could be poured 
around the sterile instrumented teeth approximately 6mm up the root surface.  See figures 18 and 
19.  The following irrigation protocols were conducted with a new 3mL Monoject
®
 syringe 
equipped with a 30 gauge ProRinse
®
 side-venting needle.  3mL of each solution were utilized for 
the time indicated.  A new irrigation syringe and needle were used with each trial. 
Irrigation Protocol:   6% NaOCl – 5min 
 
   6% NaOCl – 5min  
17% EDTA – 1min 
    
   70% DMSO – 5min 
    
100% Novel Irrigant – 5min 
 
   50% Novel Irrigant – 5min 
 
   25% Novel Irrigant – 5min 
 
   100% Novel Irrigant – 5min 
   17% EDTA – 1min 
 
   17% EDTA – 1min 
    
   No Treatment – only staining 
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The teeth were then stained with an appropriate laser fluorescent confocal microscopy stain 
(Rhodamine B).  0.1mM of Rhodamine B solution was prepared by adding 23.95mg of 
Rhodamine B dye (Aldrich Chemicals, Milwaukee, WI) to 500ml of deionized water.  The dye 
was injected into the specimens with an additional new 3mL Monoject
®
 syringe with 30 gauge 
ProRinse
®
 side-venting needle.  The teeth were stained with the 0.1mM Rhodamine B and stored 
in glass screw top vials for 24 hours, with no subsequent rinsing.  See figure 19.  Rhodamine B 
from the solution incorporates into demineralized tooth structure, but does not penetrate intact 
tooth structure.  After 24 hours, the teeth were sectioned mid-root with a slow speed circular saw 
equipped with a diamond disc blade.  A second cut was then made adjacent to the initial cut to 
obtain a 0.75mm circular cross section.  The sections were then placed on a T-4 heated coverslip 
and viewed with a Zeiss laser confocal microscope using helium and neon gas at 543nm to excite 
the Rhodamine B.  Images were obtained at 10X and keeping each specimen oriented in a similar 
manner. 
 
 
Figure 12:  Radiograph of prepared sample, cross-section of sample, slow speed diamond 
disc saw 
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Figure 13:  Irrigation armamentarium, putty jig, EDTA, DMSO 
 
 
Figure 14:  Prepared samples ready for sectioning, blue acrylic material used to mount 
teeth 
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Chapter 4 
Results 
 
NMR:  Samples of Clindamycin HCl, Nystatin, in a 1:1 mixture were examined immediately 
after preparation, after standing at 25
o
C for 24 h, after 1 week, and after 1 week plus heating to 
50
o
C.  All three samples were stable and remained unchanged by NMR.  Figure 20 displays the 
partial proton NMR spectra of the three samples taken after 1 week.  The region displayed 
corresponds to the proton adjacent to the chlorine of clindamycin, which is subject to 
replacement by the amino group in Nystatin.  The set of four peaks (ratio 1:3:3:1, the quartet) is 
due to this proton.  The single peak in the Nystatin sample that is observed in this region is due 
to proton on the carbon that bears the sugar residue.  The spectrum obtained on the combined 
sample is simply the sum of the two spectra (Clindamycin HCl and Nystatin) indicating that no 
reaction occurred.  Examination of the full spectrum of the individual and combined samples 
indicated that no alternative reactions occurred (i.e., the spectrum obtained for Clindamycin 
HCl/Nystatin was merely the sum of those for Clindamycin HCl and Nystatin, Data not shown. 
 
 
 
 
 
 
 
 
 
Figure 15: Partial NMR spectrum of Clindamycin HCl, Nystatin, and a 1:1 
mixture in the range of 4.45-4.50 ppm.  The quartet in spectra of samples 
with clindamycin is due to the circled proton.  
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ZOI:  The ZOI studies indicated that the novel irrigant was effective against E. coli, S. aureus, 
and C. albicans both in the planktonic form (Mueller-Hinton) and biofilm phenotype 
(poloxamer) in all concentrations (25, 50, and 100%).  6% NaOCl was also effective against 
these organisms.  The novel irrigant did not appear to exhibit antimicrobial activity against the P. 
aeruginosa and Lactobacillus.  The NaOCl did exhibit antimicrobial activity against P. 
aeruginosa and Lactobacillus; however, after the 48 hour reading there appeared to be colonies 
forming back inside the ZOI.  Interesting to note was the fact that the solvent alone (70% 
DMSO) exhibited antibacterial activity against E. coli in both the planktonic and biofilm 
phenotype and exhibited activity against the biofilm phenotype of the C. albicans trial.  All 
concentrations of the Novel Irrigant produced a “double zone” of inhibition after 48 hours in 
both Mueller-Hinton and poloxamer trials of S. aureus. 
 37 
 
 
Figure 16:  ZOI Results of all 5 microorganisms tested, Mueller-Hinton Media (Planktonic) 
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Figure 17:  ZOI Results of all 5 microorganisms tested, Poloxamer Media (Biofilm) 
 
Five additional ZOI trials were performed with C. albicans as the test organism and the results 
were averaged.   
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 M-H POLX M-H POLX M-H POLX M-H POLX M-H POLX M-H POLX 
A1 20.15 11.54 23.18 11.41 23.04 10.79 23.57 10.15 22.83 8.49 22.53 7.47 
A2 22.08 11.07 23.01 10.77 24.4 11.75 25.04 11.46 22.52 9.57 21.52 8.46 
B1 15.67 9.9 18.03 10.63 20.18 9.98 19.82 10.61 18.43 9.28 20.41 7.24 
B2 17.03 9.74 18.51 10.66 21.58 12.03 20.79 11.08 19.39 10.27 19.59 8.23 
C1 14.97 8.23 15.9 8.78 16.75 10.42 15.85 8.47 16.27 7.78 16.39 7.13 
C2 15.42 9.32 15.26 9.23 17.88 9.86 17.55 9.49 16.03 8.63 16.17 8.15 
D1 0 0 0 0 0 0 0 0 0 0 0 0 
D2 0 0 0 0 0 0 0 0 0 0 0 0 
E 0 7.76 0 7.6 0 8.43 0 8.41 0 7.53 0 7 
F 76.68 63.49 73.4 75.33 61.45 78.53 62.24 82.24 66.17 77.06 68.11 81.06 
 
Table 1:  Zones of Inhibition Study, C. albicans, 24-hr incubation period (all measurements 
in mm) 
 
A = 100% Concentration of New Product 
B = 50% Concentration of New Product 
C = 25% Concentration of New Product 
D = 0 % Concentration of New Product (control) 
E = Solvent Alone (70% DMSO) 
F = 6% NaOCl 
  
M-H = Mueller Hinton Media (Planktonic) 
POLX = Poloxamer Media (Biofilm) 
 
 
 
  (C. albicans) 
  Muller - Hinton Poloxamer 
A Avg 22.8225 10.244167 
Std Dev A 1.270004474 1.4289313 
B Avg 19.11916667 9.9708333 
Std Dev B 5.53882335 1.2756992 
C Avg 16.20333333 8.7908333 
Std Dev C 0.865262265 0.9240864 
D Avg 0 0 
Std Dev D 0 0 
E Avg 0 7.7883333 
Std Dev E 0 0.5518484 
F Avg 68.00833333 76.285 
Std Dev F 6.065362039 6.7605821 
 
Table 2:  ZOI results of C. albicans trials (AVG and STD DEV) 
 40 
 
 
Figure 18:  ZOI Results C. albicans (Average of trials n=12), Mueller-Hinton Media 
(Planktonic) 
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Figure 19:  ZOI Results C. albicans (Average of trials n=12) Poloxamer Media (Biofilm) 
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irrigant was more effective than the solvent alone (p-Value <.0001) and 25% concentration (p-
Value 0.0160).  The 25% concentration was significantly more effective than the solvent alone 
(p-Value <.0001). 
CFU:  The CFU assay showed that there was no significant difference in the anti-microbial 
ability of 6% NaOCl when compared to 100% concentration of the novel irrigant. 
A = 100% Concentration of New Product 
B = 50% Concentration of New Product 
C = 25% Concentration of New Product 
D = 0 % Concentration of New Product 
E = Solvent Alone (70% DMSO) 
F = 6% NaOCl 
500 signifies that the colonies were too numerous to count and was used for statistical purposes 
  
Dilution 
 
10-2      
 
 
10-4      
 
 
10-6      
Trial 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 
A 93 71 56 102 68 87 2 0 0 3 0 0 0 0 0 0 0 0 
B 183 135 219 237 196 272 4 3 5 7 2 6 0 0 0 1 0 0 
C  140 193 89 173 87 67 3 5 2 4 3 3 0 1 0 1 1 1 
D 500 500 500 500 500 500 37 42 66 49 56 29 1 3 4 1 3 1 
E 6 11 8 5 13 1 2 3 1 0 1 0 0 1 0 0 0 0 
F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
Table 3:  CFU Assay, C. albicans Results of each trial (n=6), number of colonies present at 
given dilutions. 
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Dilution    AVG 10-2 10-4 10-6 
A = 100% Concentration of 
New Product   8.33*103 79.5 0.833333 0 
B = 50% Concentration of 
New Product   4.5*104 207 4.5 0.166667 
C = 25% Concentration of 
New Product   3.3*104 124.8333 3.333333 0.666667 
D = 0 % Concentration of 
New Product   4.65*105 500 46.5 2.166667 
E = Solvent Alone (70% 
DMSO)   1.16*104 7.333333 1.166667 0.166667 
F = 6% NaOCl   0 0 0 0 
Table 4:  Average of CFU Assay Results C. albicans 
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Figure 20:  Graph of CFU Assay C. albicans Results 
 
Optical Density Absorbance:  The absorbance assay showed that the 100% concentration of the 
novel irrigant was more effective than 6% NaOCl and all other concentrations of the novel 
irrigant at biofilm removal.  The solvent alone showed similar results.  The positive control did 
not respond as expected, this could be due to the fact that untreated biofilm is easily removed 
from the plastic pegs by the glacial acetic acid.  A lower absorbance value was indicative of 
greater solution anti-microbial activity.  
0
50000
100000
150000
200000
250000
300000
350000
400000
450000
500000
C
FU
s 
Treatment 
Colony Forming Units 
C. albicans 
Series1
 45 
 
Optical Density Absorbance Data recorded at 562nm   
  C. albicans 
A = 100% Concentration of New Product 0.786 
B = 50% Concentration of New Product 0.83 
C = 25% Concentration of New Product 0.818 
D = 0 % Concentration of New Product 0.765 
E = Solvent Alone (70% DMSO) 0.787 
F = 6% NaOCl 0.843 
 
Table 5:  Results of Absorbance Assay, C. albicans 
 
 
Figure 21:  Graph showing results of Optical Density Absorbance Assay, C. albicans 
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SEM Photography:  The SEM assay confirmed the presence of biofilm on the pegs of our 
Calgary Biofilm Device.  Different stages of biofilm growth were observed ranging from 
budding yeast cells, to pseudo-hyphae, and the more pathogenic hyphae phase.  This assay 
clearly demonstrated the bi-phasic nature of this eukaryotic organism, C. albicans. 
 
Figure 22:  Bi-phasic budding yeast (Stage III), hyphae and pseudo-hyphae (Stage I)  
 
 
Figure 23:  Isolated single yeast cells 
 47 
 
  
Figure 24:  Pseudo hyphae, penetrating hyphae, example of bi-phasic eukaryote 
 
Coverage Area Assay:  The results of the biofilm coverage assay showed that 100% and 25% 
concentration of the novel irrigant were twice as effective at removing biofilm from the pegs of 
the Calgary Biofilm Device when compared to NaOCl.  The 100% concentration of the novel 
irrigant was significantly better than NaOCl (p-Value 0.0059).  25% concentration was also 
significantly better than NaOCl (p-Value 0.0085).  There was no significant difference in the 
amount of biofilm coverage remaining when comparing the three concentrations of the novel 
irrigant to each other as well as the solvent (70% DMSO) alone.  The corresponding images on 
the following pages are in order from left to right, the original crystal violet stained image (as 
viewed under the microscope) that has been cropped for consistency in all samples, an 8-bit 
converted black and white image, the image with the threshold value adjusted to be inclusive of 
the area of biofilm coverage, and computer analysis of area measurement. 
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Figure 25:  Graph of Biofilm Coverage Area Assay, C. albicans 
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Figure 26:  100% Concentration of Novel Irrigant:  The following represents, in order 
from left to right, original image obtained from the Zeiss Microscope at 5X, 8-bit Black and 
White image, Image adjusted with threshold value, and computer analysis of coverage area 
 
 
 
Figure 27:  50% Concentration of Novel Irrigant 
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Figure 28: 25% Concentration of Novel Irrigant  
 
 
 
Figure 29: 70% DMSO (Solvent Alone)  
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Figure 30:  No Treatment (Positive Control) 
 
 
 
Figure 31: 6% NaOCl  
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Penetration Study:  The results of the penetration study showed that the mean penetration (in 
micrometers) of each tested combination into dentin tubules of extracted human teeth were as 
follows: 
100% 
Novel 
EDTA/ 
DMSO 
25% 
Novel 
70% 
DMSO 
50% 
Novel 
EDTA/100% 
Novel 
17% 
EDTA 
EDTA/ 
NaOCl 
6% 
NaOCl 
No 
Treat 
601.52 362.26 311.05 308.33 276.59 257.03 140.30 129.44 77.27 17.55 
 
 
Figure 32:  Graph of Penetration into Dentin Tubules (micrometers) 
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The 100% concentration of the novel irrigant penetrated significantly further into the dentin 
tubules of extracted human teeth when compared to the no treatment group (p-value <0.0001), 
6% NaOCl (p-value <0.0001), combination of 17% EDTA and 6% NaOCl (p-value <0.0001), 
and 17% EDTA alone (p-value <0.0001). 
 
  
 54 
 
 
 
Control:  No Treatment 
 
 
25% Concentration of Novel Irrigant 
 
 
50% Concentration of Novel Irrigant 
 
 
100% Concentration of Novel Irrigant 
 
Figure 33:  Comparison of Control and all concentrations of Novel Irrigant Tested 
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Figure 34:  Confocal Laser Microscopy 10X No treatment 
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Figure 35:  Confocal Laser Microscopy 10X 6% NaOCl Treatment 
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Figure 36:  Confocal Laser Microscopy 17% EDTA Treatment 
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Figure 37: Confocal Laser Microscopy 10X 70% DMSO Treatment  
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Figure 38: Confocal Laser Microscopy 10X 100% Concentration of Novel Irrigant   
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Figure 39:  Confocal Laser Microscopy 10X 50% Concentration of Novel Irrigant 
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Figure 40: Confocal Laser Microscopy 25% Concentration of Novel Irrigant  
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Figure 41:  Confocal Laser Microscopy 10X Treatment with 17% EDTA and 6% NaOCl 
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Figure 42:  Confocal Laser Microscopy 20X 100% Concentration Novel Irrigant 
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Discussion 
 
As with any in vitro or bench top study, differences in results may be attributed to 
variations in specimens, testing procedures, instrumentation/experimentation techniques and 
interpretation of data.  One advantage of in vitro testing is that it provides a reasonable method 
for technique examination and observation without the many restrictions found in a clinical 
setting.  Conversely, it is difficult, if not impossible, for in vitro studies to reproduce clinical 
conditions.  Conclusive evidence regarding efficacy should be drawn from many studies 
conducted by independent investigators looking at similar technique aspects, animal trials, and 
from history of clinical use. 
 The present study was designed to formulate and evaluate the ability of a novel irrigant in 
different concentrations (25, 50, and 100%) to have anti-microbial activity against a recalcitrant 
C. albicans biofilm as well as observe penetration of the irrigant into the dentin tubules of root 
canals prepared in an identical manner.  Comparable levels of disinfection were found between 
the novel irrigant and full strength (6%) NaOCl.  Superior penetration into dentin tubules was 
found with 100% concentration of the novel irrigant when compared to NaOCl and 17% EDTA 
or some combination of the two.  All of the positive controls demonstrated microbial growth and 
did not show penetration into the dentin tubules supporting the experimental design. 
Prepared root canals by conventional standards are chemically disinfected using some 
form of irrigation.  The ability to chemically disinfect areas of root canals that are inaccessible to 
instrumentation has been considered to be essential for clinical success.  Irrigation materials can 
reach fins, apical deltas, and lateral canals, thus improving the outcome of non-surgical root 
canal therapy.   Unfortunately, all irrigants suffer physical short-comings such as inability to 
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penetrate deep into the dentin tubules and address remaining microorganisms that these areas 
harbor.  These undesirable characteristics are incompatible with long-term endodontic success, 
especially when dealing with extraradicular biofilms.  The objective of irrigation is to minimize 
the amount of bio load (microorganisms) present in the canal system while leaving the remaining 
dentin occupying the root canal unharmed.   
 Full strength NaOCl was used in this study as the control irrigant because of its known 
clinical success and history of use.   
Recently, the materials such as MTAD
®
 and QMIX
®
 have attempted to replace NaOCl 
and the potential dangers associated with its use.  At best, these new materials can be used as 
adjuncts with some degree of clinical success.  Use of other less harmful irrigation materials can 
potentially decrease the chance of a sodium hypochlorite accident.   However, no other 
endodontic irrigant seems to possess the ability to dissolve tissue like that of NaOCl. 
Some studies have concluded that irrigants such as QMIX
®
 when used according to 
manufacturer’s recommendations have the ability to better disinfect root canal systems while 
removing the smear layer when compared to NaOCl and EDTA or some combination of the two.   
The experimental groups studied containing DMSO were the only groups that 
demonstrated statistically significant ability to remove biofilm from pegs of the Calgary Biofilm 
Device.  In addition, the 100% concentration of novel irrigant was statistically significant in its 
ability to penetrate into the dentin tubules of a prepared root canal. 
After NMR analysis of the newly formulated mixture there appears to be no reaction 
between any of the ingredients, Clindamycin, Nystatin, and Dimethyl sulfoxide.  The NMR 
spectroscopy study confirms the stability of the mixture.  The concern always exists that this 
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mixture may potentially have interactions with other commonly utilized endodontic irrigants, but 
this question requires further testing in a laboratory setting.  There is also always the possibility 
that certain patients may have or develop allergies to certain drugs.  Clindamycin does not appear 
to be the allergen that other commonly used antibiotics (penicillin based drugs) seem to be; 
however, there is always the risk of developing Pseudomembranous colitis with the use of 
antibiotics.  It is assumed that the dose of Clindamycin in this particular formulation is relatively 
low compared to an oral regimen of the drug and will not leave the root canal system.  Nystatin 
is a commonly used antifungal agent, and hence the reason it was chosen for this formulation.  It 
too can potentially be an allergen for some patients, though this is seen as an extremely rare 
occurrence.  Dimethyl sulfoxide has currently only gained FDA approval in the treatment of 
bladder inflammation or interstitial cystitis.  There is concern over whether or not DMSO could 
further denature collagen perhaps causing damage to the tooth structure.  DMSO absorbed 
systemically is primarily excreted in the urine and the only listed side effect is a garlic-like odor 
on the breath.  Again the rather miniscule amount of DMSO that the patient would be exposed to 
is quite small in this application and no adverse effects are anticipated.  Further testing is 
required to verify this hypothesis.  Derivatives of DMSO could possibly be substituted as a more 
biocompatible solvent. 
 The ZOI study demonstrated that all concentrations of the novel irrigant resulted in 
disinfection activity against E. coli, S. aureus, and C. albicans, as did full strength NaOCl.  The 
novel irrigant did not show activity against P. aeruginosa or Lactobacillus.  This was true for 
both the planktonic simulation with Mueller-Hinton agar and the biofilm phenotype simulation 
with Poloxamer plates.  Full strength NaOCl was significantly more effective than the novel 
irrigant in the ZOI study.  DMSO alone had activity against the biofilm phenotype of both E. coli 
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and C. albicans.  While NaOCl did show some activity against P. aeruginosa and Lactobacillus 
after 24 hours, when viewed at 48 hours, it was apparent that colonies had re-grown inside the 
original zone of inhibition.  Because C. albicans was the organism chosen for this study, further 
trials were repeated yielding similar results in both the planktonic and biofilm phenotypes.  
Because of these results and the unknown variable of whether or not the novel irrigant will 
possess the ability to dissolve tissue, it may be that the novel irrigant will not replace the use of 
NaOCl; rather it could be used as an adjunct to endodontic irrigation. 
 Pegs from the Calgary Biofilm Device were used to complete three different assays as 
well as obtain SEM images to verify biofilm formation.  Six independent trials of performing 
colony forming unit dilutions were conducted using C. albicans as the test organism.  Biofilm 
remaining after treatment was removed via sonication, serial dilutions were performed with 
physiologic saline, plated on M-H, and results were quantified using an aCOLyte colony counter.  
A colony forming unit is used to determine the number of viable bacterial cells in a sample per 
mL.  A lower CFU is indicative of greater solution activity.  The results suggest similar 
antimicrobial activity as compared to full strength NaOCl.  Although the NaOCl showed no 
growth, this was not significantly different to the different concentrations of the novel irrigant 
when compared with the positive control value. 
 The crystal violet assay involved staining the biofilm covered plastic pegs and viewing 
under a Zeiss tissue microscope.  Representative photographs were taken with a Nikon digital 
capture device.  These photos were then cropped at a consistent orientation and size and 
converted to scale as an 8-bit gray image.  Computer software was able to allow the observer to 
select the darker areas on the image which corresponded to remaining biofilm on the pegs.  The 
computer software was able to map out the dark areas that were selected and obtain an average 
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area of coverage.  The larger the dark area, corresponded with the more remaining biofilm, and 
therefore the less effective treatment solution.  The novel irrigant did appear to have a 
significantly better ability to remove biofilm from the Calgary Biofilm Device compared to full 
strength NaOCl.  The process of selecting the dark areas was a bit subjective; however, identical 
sample sizes were taken from each peg at the same location and consistent threshold values were 
used. 
 The absorbance assay was conducted after the remaining biofilm (having been treated 
with a specific treatment) was stained with crystal violet, washed with deionized water and 
removed from the peg into glacial acetic acid.  The absorbance of the glacial acetic acid was read 
at a fixed wavelength of 562nm.  A lower absorbance value was indicative of greater solution 
antimicrobial activity (Trotonda 2008).  These results also suggest that the novel irrigant 
possesses better anti-biofilm activity compared to NaOCl. 
 The positive control C. albicans peg was viewed under SEM and representative 
photographs were taken to ensure biofilm formation.  Quantitative analysis to determine the 
amount of actual biofilm coverage was unable to be computed due to variability and orientation 
of the pegs. 
 The penetration study showed that the 100% concentration of the novel irrigant was 
statistically more significant in its ability to penetrate the dentin tubules of extracted human teeth 
when compared with current irrigation protocols.  This characteristic sets the novel irrigant apart 
from other endodontic irrigation materials and is quite unique. 
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Chapter 5 
Conclusion 
The present study indicated that a novel irrigant composed of Clindamycin, Nystatin, and 
70% DMSO has equal or better ability to disinfect a recalcitrant C. albicans biofilm phenotype 
when compared to 6% NaOCl as observed through the CFU, absorbance, and biofilm coverage 
area assays performed using the Calgary Biofilm Device.  100% Concentration of the novel 
irrigant was statistically significant in its ability to penetrate into the dentin tubules of a prepared 
root canal in an extracted human tooth when compared to 6% NaOCl and 17% EDTA.  Although 
the clinician should examine many studies and rely on clinically proven methods before 
choosing one technique or material over another, it is logical to place value in further research 
and evaluation of a technique or material which has been shown to provide disinfection and 
penetration in-vitro.  Further studies are necessary to evaluate the in-vivo success of cases which 
have been irrigated in this manner.  It must be remembered that there are numerous other factors 
that contribute to endodontic success.  Ray and Trope concluded that the quality of the coronal 
seal is equally important to the successful outcome of endodontic therapy as is the quality of the 
apical seal (Ray 1995).  Other authors agree in the importance of appropriate obturation, apical 
seal, and restoration in addition to an irrigation protocol that is effective. 
 All groups tested had similar disinfecting abilities, with the exception being 6% NaOCl in 
the ZOI studies which demonstrated that it may have superior ability to disinfect selected 
pathogens on agar plates.  This in vitro study supports the need to continue research and 
development on a novel irrigant that not only has the ability to effectively disinfect root canal 
systems, but also has the ability to penetrate into the dentin tubules and address a bio load that 
has previously been inaccessible by modern irrigation materials and protocols.  
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Appendix 1:  Statistics 
    
Rsquare 0.988755 
Adj Rsquare 0.987714 
Root Mean Square Error 2.110992 
Mean of Response 18.42983 
Observations (or Sum Wgts) 60 
Table 6:  One-way Analysis of Data (ANOVA, Summary of Fit) ZOI Study C. albicans, 
Mueller - Hinton (Planktonic) 
 
 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Treat 5 21158.760 4231.75 949.6140 <.0001* 
Error 54 240.639 4.46   
C. Total 59 21399.399    
Table 7:  ANOVA, ZOI C. albicans, Mueller-Hinton (Planktonic) 
 
 
Level Number Mean Std Error Lower 95% Upper 95% 
A 12 22.8225 0.60939 21.60 24.044 
B 12 19.1192 0.60939 17.90 20.341 
C 12 16.2033 0.60939 14.98 17.425 
D 12 0.0000 0.60939  -1.22 1.222 
E 6 0.0000 0.86181  -1.73 1.728 
F 6 68.0083 0.86181 66.28 69.736 
Table 8:  Means of One-way ANOVA, ZOI, C. albicans, Mueller-Hinton (Planktonic) 
 
 
A=100% Concentration of Novel Irrigant 
B=50% Concentration of Novel Irrigant 
C=25% Concentration of Novel Irrigant 
D=No Treatment (Positive Control) 
E=70% DMSO (Solvent Only) 
F=6% NaOCl 
Std Error uses a pooled estimate of error variance 
 
 
 
Confidence Quantile 
q* Alpha 
2.95448 0.05 
Table 9:  Means Comparisons for all pairs using Tukey-Kramer HSD, ZOI C. albicans,   
M-H (Planktonic) 
 
 
Abs(Dif)-HSD F A B C D E 
F -3.601 42.067 45.771 48.687 64.890 64.407 
A 42.067 -2.546 1.157 4.073 20.276 19.704 
B 45.771 1.157 -2.546 0.370 16.573 16.001 
C 48.687 4.073 0.370 -2.546 13.657 13.085 
D 64.890 20.276 16.573 13.657 -2.546 -3.118 
E 64.407 19.704 16.001 13.085 -3.118 -3.601 
Table 10:  LSD Threshold Matrix, ZOI C. albicans, M-H 
Positive values show pairs of means that are significantly different. 
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Level             Mean 
F A          68.008333 
A   B        22.822500 
B     C      19.119167 
C       D    16.203333 
D         E  0.000000 
E         E  0.000000 
Table 11: Connecting Letters Report, ZOI C. albicans, M-H  
Levels not connected by same letter are significantly different. 
 
 
Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
F D 68.00833 1.055496 64.8899 71.12678 <.0001*  
F E 68.00833 1.218782 64.4075 71.60920 <.0001*  
F C 51.80500 1.055496 48.6866 54.92345 <.0001*  
F B 48.88917 1.055496 45.7707 52.00761 <.0001*  
F A 45.18583 1.055496 42.0674 48.30428 <.0001*  
A D 22.82250 0.861809 20.2763 25.36870 <.0001*  
A E 22.82250 1.055496 19.7041 25.94095 <.0001*  
B D 19.11917 0.861809 16.5730 21.66537 <.0001*  
B E 19.11917 1.055496 16.0007 22.23761 <.0001*  
C D 16.20333 0.861809 13.6571 18.74953 <.0001*  
C E 16.20333 1.055496 13.0849 19.32178 <.0001*  
A C 6.61917 0.861809 4.0730 9.16537 <.0001*  
A B 3.70333 0.861809 1.1571 6.24953 0.0010*  
B C 2.91583 0.861809 0.3696 5.46203 0.0160*  
E D 0.00000 1.055496  -3.1184 3.11845 1.0000  
Table 12:  Ordered Differences Report, ZOI C. albicans, M-H 
 
 
    
Rsquare 0.98957 
Adj Rsquare 0.988604 
Root Mean Square Error 2.276308 
Mean of Response 14.2085 
Observations (or Sum Wgts) 60 
Table 13:  One-way Analysis of Data (Summary of Fit) ZOI C. albicans Poloxamer 
(Biofilm) 
 
 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Treat 5 26547.138 5309.43 1024.674 <.0001* 
Error 54 279.805 5.18   
C. Total 59 26826.944    
Table 14:  Analysis of Variance, ZOI C. albicans (Biofilm) 
 
 
Level Number Mean Std Error Lower 95% Upper 95% 
A 12 10.2442 0.65711 8.93 11.562 
B 12 9.9708 0.65711 8.65 11.288 
C 12 8.7908 0.65711 7.47 10.108 
D 12 0.0000 0.65711  -1.32 1.317 
E 6 7.7883 0.92930 5.93 9.651 
F 6 76.2850 0.92930 74.42 78.148 
Table 15:  Means of One-way ANOVA, ZOI C. albicans (Biofilm) 
Std Error uses a pooled estimate of error variance 
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Confidence Quantile 
q* Alpha 
2.95448 0.05 
Table 16:  Means Comparisons for all pairs using Tukey-Kramer HSD, ZOI C. albicans 
(Biofilm) 
 
 
Abs(Dif)-HSD F A B C E D 
F -3.883 62.678 62.952 64.132 64.614 72.922 
A 62.678 -2.746 -2.472 -1.292 -0.907 7.499 
B 62.952 -2.472 -2.746 -1.566 -1.180 7.225 
C 64.132 -1.292 -1.566 -2.746 -2.360 6.045 
E 64.614 -0.907 -1.180 -2.360 -3.883 4.426 
D 72.922 7.499 7.225 6.045 4.426 -2.746 
Table 17:  LSD Threshold Matrix, ZOI C. albicans (Biofilm) 
Positive values show pairs of means that are significantly different. 
 
 
Level             Mean 
F A        76.285000 
A   B      10.244167 
B   B      9.970833 
C   B      8.790833 
E   B      7.788333 
D     C    0.000000 
Table 18:  Connecting Letters Report, ZOI C. albicans (Biofilm) 
Levels not connected by same letter are significantly different. 
 
 
 
Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
F D 76.28500 1.138154 72.9223 79.64766 <.0001*  
F E 68.49667 1.314227 64.6138 72.37953 <.0001*  
F C 67.49417 1.138154 64.1315 70.85682 <.0001*  
F B 66.31417 1.138154 62.9515 69.67682 <.0001*  
F A 66.04083 1.138154 62.6782 69.40349 <.0001*  
A D 10.24417 0.929299 7.4986 12.98976 <.0001*  
B D 9.97083 0.929299 7.2252 12.71643 <.0001*  
C D 8.79083 0.929299 6.0452 11.53643 <.0001*  
E D 7.78833 1.138154 4.4257 11.15099 <.0001*  
A E 2.45583 1.138154  -0.9068 5.81849 0.2744  
B E 2.18250 1.138154  -1.1802 5.54516 0.4029  
A C 1.45333 0.929299  -1.2923 4.19893 0.6253  
B C 1.18000 0.929299  -1.5656 3.92560 0.7999  
C E 1.00250 1.138154  -2.3602 4.36516 0.9495  
A B 0.27333 0.929299  -2.4723 3.01893 0.9997  
Table 19:  Ordered Differences Report, ZOI C. albicans (Biofilm) 
    
Rsquare 0.641112 
Adj Rsquare 0.581297 
Root Mean Square Error 0.628048 
Mean of Response 0.527778 
Observations (or Sum Wgts) 36 
Table 20:  One-way ANOVA Analysis of CFU (Summary of Fit) C. albicans, Dilution=10
-6
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Source DF Sum of Squares Mean Square F Ratio Prob > F 
Trial: 5 21.138889 4.22778 10.7183 <.0001* 
Error 30 11.833333 0.39444   
C. Total 35 32.972222    
Table 21:  Analysis of Variance, C. albicans, CFU Dilution=10
-6
 
 
 
Level Number Mean Std Error Lower 95% Upper 95% 
A 6 0.00000 0.25640  -0.524 0.5236 
B 6 0.16667 0.25640  -0.357 0.6903 
C 6 0.66667 0.25640 0.143 1.1903 
D 6 2.16667 0.25640 1.643 2.6903 
E 6 0.16667 0.25640  -0.357 0.6903 
F 6 0.00000 0.25640  -0.524 0.5236 
Table 22:  Means for One-way ANOVA, C. albicans, CFU Dilution=10
-6
 
Std Error uses a pooled estimate of error variance 
 
 
Level Count Score Sum Expected Score Score Mean (Mean-Mean0)/Std0 
A 6 75.000 111.000 12.5000  -1.816 
B 6 91.500 111.000 15.2500  -0.972 
C 6 141.000 111.000 23.5000 1.509 
D 6 192.000 111.000 32.0000 4.118 
E 6 91.500 111.000 15.2500  -0.972 
F 6 75.000 111.000 12.5000  -1.816 
Table 23:  Wilcoxon / Kruskal-Wallis Tests (Rank Sums), C. albicans, CFU Dilution=10
-6
 
 
 
ChiSquare DF Prob>ChiSq 
23.5852 5 0.0003* 
Table 24:  1-way Test, ChiSquare Approximation, C. albicans, CFU Dilution=10
-6
 
Confidence Quantile 
 
 
q* Alpha 
3.04160 0.05 
Table 25:  Means Comparisons for all pairs using Tukey-Kramer HSD, C. albicans, CFU 
Dilution=10
-6
 
 
 
 
 
 
Abs(Dif)-HSD 
D C B E A F 
D -1.1029 0.3971 0.8971 0.8971 1.0638 1.0638 
C 0.3971 -1.1029 -0.6029 -0.6029 -0.4362 -0.4362 
B 0.8971 -0.6029 -1.1029 -1.1029 -0.9362 -0.9362 
E 0.8971 -0.6029 -1.1029 -1.1029 -0.9362 -0.9362 
A 1.0638 -0.4362 -0.9362 -0.9362 -1.1029 -1.1029 
F 1.0638 -0.4362 -0.9362 -0.9362 -1.1029 -1.1029 
Table 26:  LSD Threshold Matrix, C. albicans, CFU Dilution=10
-6
 
Positive values show pairs of means that are significantly different. 
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Level             Mean 
D A       2.1666667 
C   B     0.6666667 
B   B     0.1666667 
E   B     0.1666667 
A   B     0.0000000 
F   B     0.0000000 
Table 27:  Connecting Letters Report, C. albicans, CFU Dilution=10
-6
 
Levels not connected by same letter are significantly different. 
 
 
Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
D A 2.166667 0.3626038 1.06377 3.269561 <.0001*  
D F 2.166667 0.3626038 1.06377 3.269561 <.0001*  
D B 2.000000 0.3626038 0.89711 3.102895 <.0001*  
D E 2.000000 0.3626038 0.89711 3.102895 <.0001*  
D C 1.500000 0.3626038 0.39711 2.602895 0.0033*  
C A 0.666667 0.3626038  -0.43623 1.769561 0.4577  
C F 0.666667 0.3626038  -0.43623 1.769561 0.4577  
C B 0.500000 0.3626038  -0.60289 1.602895 0.7389  
C E 0.500000 0.3626038  -0.60289 1.602895 0.7389  
B A 0.166667 0.3626038  -0.93623 1.269561 0.9972  
E A 0.166667 0.3626038  -0.93623 1.269561 0.9972  
B F 0.166667 0.3626038  -0.93623 1.269561 0.9972  
E F 0.166667 0.3626038  -0.93623 1.269561 0.9972  
E B 0.000000 0.3626038  -1.10289 1.102895 1.0000  
F A 0.000000 0.3626038  -1.10289 1.102895 1.0000  
Table 28:  Ordered Differences Report, C. albicans, CFU Dilution=10
-6
 
 
 
    
Rsquare 0.91475 
Adj Rsquare 0.900542 
Root Mean Square Error 5.573748 
Mean of Response 9.388889 
Observations (or Sum Wgts) 36 
Table 29:  One-way ANOVA Analysis of CFU (Summary of Fit) C. albicans, CFU 
Dilution=10
-4
  
 
 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Trial: 5 10000.556 2000.11 64.3813 <.0001* 
Error 30 932.000 31.07   
C. Total 35 10932.556    
Table 30:  Analysis of Variance, C. albicans, CFU Dilution=10
-4
  
 
 
Level Number Mean Std Error Lower 95% Upper 95% 
A 6 0.8333 2.2755  -3.81 5.480 
B 6 4.5000 2.2755  -0.15 9.147 
C 6 3.3333 2.2755  -1.31 7.980 
D 6 46.5000 2.2755 41.85 51.147 
E 6 1.1667 2.2755  -3.48 5.814 
F 6 0.0000 2.2755  -4.65 4.647 
Table 31:  Means for One-way ANOVA, C. albicans, CFU Dilution=10
-4
 
Std Error uses a pooled estimate of error variance 
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Level Count Score Sum Expected Score Score Mean (Mean-Mean0)/Std0 
A 6 64.000 111.000 10.6667  -2.018 
B 6 150.000 111.000 25.0000 1.671 
C 6 134.000 111.000 22.3333 0.976 
D 6 201.000 111.000 33.5000 3.883 
E 6 78.000 111.000 13.0000  -1.410 
F 6 39.000 111.000 6.5000  -3.102 
Table 32:  Wilcoxon / Kruskal-Wallis Tests (Rank Sums), C. albicans, CFU Dilution=10
-4
 
 
 
ChiSquare DF Prob>ChiSq 
29.2326 5 <.0001* 
Table 33: 1-way Test, ChiSquare Approximation, C. albicans, CFU Dilution=10
-4
 
 
 
Level             Mean 
D A       46.500000 
B   B     4.500000 
C   B     3.333333 
E   B     1.166667 
A   B     0.833333 
F   B     0.000000 
Table 34: Connecting Letters Report, C. albicans, CFU Dilution=10
-4
  
Levels not connected by same letter are significantly different. 
 
 
Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
D F 46.50000 3.218005 36.7121 56.28788 <.0001*  
D A 45.66667 3.218005 35.8788 55.45454 <.0001*  
D E 45.33333 3.218005 35.5455 55.12121 <.0001*  
D C 43.16667 3.218005 33.3788 52.95454 <.0001*  
D B 42.00000 3.218005 32.2121 51.78788 <.0001*  
B F 4.50000 3.218005  -5.2879 14.28788 0.7276  
B A 3.66667 3.218005  -6.1212 13.45454 0.8609  
C F 3.33333 3.218005  -6.4545 13.12121 0.9020  
B E 3.33333 3.218005  -6.4545 13.12121 0.9020  
C A 2.50000 3.218005  -7.2879 12.28788 0.9694  
C E 2.16667 3.218005  -7.6212 11.95454 0.9836  
E F 1.16667 3.218005  -8.6212 10.95454 0.9991  
B C 1.16667 3.218005  -8.6212 10.95454 0.9991  
A F 0.83333 3.218005  -8.9545 10.62121 0.9998  
E A 0.33333 3.218005  -9.4545 10.12121 1.0000  
Table 35: Ordered Differences Report, C. albicans, CFU Dilution=10
-4
   
 
 
    
Rsquare 0.97572 
Adj Rsquare 0.971673 
Root Mean Square Error 29.44015 
Mean of Response 153.1111 
Observations (or Sum Wgts) 36 
Table 36: One-way ANOVA Analysis of CFU (Summary of Fit) C. albicans, CFU 
Dilution=10
-2
 
 
 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Trial: 5 1044889.9 208978 241.1130 <.0001* 
Error 30 26001.7 867   
C. Total 35 1070891.6    
Table 37:  Analysis of Variance, C. albicans, CFU Dilution=10
-2
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Level Number Mean Std Error Lower 95% Upper 95% 
A 6 79.500 12.019 55.0 104.05 
B 6 207.000 12.019 182.5 231.55 
C 6 124.833 12.019 100.3 149.38 
D 6 500.000 12.019 475.5 524.55 
E 6 7.333 12.019  -17.2 31.88 
F 6 0.000 12.019  -24.5 24.55 
Table 38:  Means for One-way ANOVA, C. albicans, CFU Dilution=10
-2
 
Std Error uses a pooled estimate of error variance 
 
 
Level Count Score Sum Expected Score Score Mean (Mean-Mean0)/Std0 
A 6 102.500 111.000 17.0833  -0.341 
B 6 161.000 111.000 26.8333 2.111 
C 6 123.500 111.000 20.5833 0.512 
D 6 201.000 111.000 33.5000 3.817 
E 6 57.000 111.000 9.5000  -2.281 
F 6 21.000 111.000 3.5000  -3.817 
Table 39: Wilcoxon / Kruskal-Wallis Tests (Rank Sums), C. albicans, CFU Dilution=10
-2
 
 
 
ChiSquare DF Prob>ChiSq 
33.1020 5 <.0001* 
Table 40:  1-way Test, ChiSquare Approximation, C. albicans, CFU Dilution=10
-2
 
 
Confidence Quantile 
q* Alpha 
3.04160 0.05 
Table 41: Means Comparisons for all pairs using Tukey-Kramer HSD, C. albicans, CFU 
Dilution=10
-2
  
 
 
Abs(Dif)-HSD D B C A E F 
D -51.70 241.30 323.47 368.80 440.97 448.30 
B 241.30 -51.70 30.47 75.80 147.97 155.30 
C 323.47 30.47 -51.70 -6.37 65.80 73.13 
A 368.80 75.80 -6.37 -51.70 20.47 27.80 
E 440.97 147.97 65.80 20.47 -51.70 -44.37 
F 448.30 155.30 73.13 27.80 -44.37 -51.70 
Table 42: LSD Threshold Matrix, C. albicans, CFU Dilution=10
-2
  
 Positive values show pairs of means that are significantly different. 
 
 
Level             Mean 
D A         500.00000 
B   B       207.00000 
C     C     124.83333 
A     C     79.50000 
E       D   7.33333 
F       D   0.00000 
Table 43:  Connecting Letters Report, C. albicans, CFU Dilution=10
-2
 
Levels not connected by same letter are significantly different. 
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Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
D F 500.0000 16.99728 448.301 551.6989 <.0001*  
D E 492.6667 16.99728 440.968 544.3655 <.0001*  
D A 420.5000 16.99728 368.801 472.1989 <.0001*  
D C 375.1667 16.99728 323.468 426.8655 <.0001*  
D B 293.0000 16.99728 241.301 344.6989 <.0001*  
B F 207.0000 16.99728 155.301 258.6989 <.0001*  
B E 199.6667 16.99728 147.968 251.3655 <.0001*  
B A 127.5000 16.99728 75.801 179.1989 <.0001*  
C F 124.8333 16.99728 73.134 176.5322 <.0001*  
C E 117.5000 16.99728 65.801 169.1989 <.0001*  
B C 82.1667 16.99728 30.468 133.8655 0.0005*  
A F 79.5000 16.99728 27.801 131.1989 0.0008*  
A E 72.1667 16.99728 20.468 123.8655 0.0024*  
C A 45.3333 16.99728  -6.366 97.0322 0.1122  
E F 7.3333 16.99728  -44.366 59.0322 0.9979  
Table 44:  Ordered Differences Report, C. albicans, CFU Dilution=10
-2
 
 
 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
RawIntDen 3 4 1.0059e+10 2.5147e+9 3.1006 0.0159* 
Error 309 2.5061e+11 811029508   
C. Total 313 2.6067e+11    
Table 45: One-way Analysis of Variance of Area of Biofilm Coverage on Pegs of Calgary 
Biofim Device (C. albicans) 
 
 
Level Number Mean Std Error Lower 95% Upper 95% 
100% Novel Irrigant  103 1686.0 2806.1  -3835 7207 
25% concentration Novel  80 2200.3 3184.0  -4065 8465 
50% concentration Novel  68 3744.0 3453.5  -3051 10539 
DMSO 51 5504.0 3987.8  -2343 13351 
NaOCl 12 31580.7 8221.1 15404 47757 
Table 46: Means for One-way ANOVA, Area of Biofilm Coverage  
Std Error uses a pooled estimate of error variance 
 
 
Confidence Quantile 
q* Alpha 
2.74396 0.05 
Table 47: Means Comparisons for all pairs using Tukey-Kramer HSD, Area of Biofilm 
Coverage  
 
 
Level             Mean 
NaOCl A       31580.742 
DMSO   B     5504.037 
50% concentration Novel 5X   B     3744.000 
25% concentration Novel 5X   B     2200.306 
100% Novel Irrigant 5x   B     1686.001 
Table 48:  Connecting Letters Report, Area of Biofilm Coverage 
Levels not connected by same letter are significantly different. 
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Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
NaOCl 100%  29894.74 8686.764 6058.6 53730.92 0.0059  
NaOCl 25%  29380.44 8816.102 5189.4 53571.51 0.0085*  
NaOCl 50%  27836.74 8916.989 3368.8 52304.65 0.0167*  
NaOCl DMSO 26076.71 9137.195 1004.6 51148.85 0.0369*  
DMSO 100% 3818.04 4876.127  -9561.9 17197.96 0.9354  
DMSO 25% 3303.73 5102.980  -10698.7 17306.13 0.9670  
50%  100% 2058.00 4449.829  -10152.2 14268.17 0.9906  
DMSO 50% 1760.04 5275.362  -12715.4 16235.45 0.9973  
50%  25%  1543.69 4697.316  -11345.6 14432.96 0.9975  
25%  100%  514.30 4244.048  -11131.2 12159.82 1.0000  
Table 49: Ordered Differences Report, Area of Biofilm Coverage  
 *Percentages reflect % of Novel concentration 
 
 
Analysis of Variance 
Source DF Sum of Squares Mean Square F Ratio Prob > F 
Treatment 9 763373.08 84819.2 19.1326 <.0001* 
Error 20 88664.51 4433.2   
C. Total 29 852037.59    
Table 50:  One-way Analysis of Variance of Penetration into Dentin Tubules of prepared 
root canals (micrometers) 
 
 
Level Number Mean Std Error Lower 95% Upper 95% 
100% Novel 3 601.520 38.441 521.3 681.71 
17% EDTA 3 140.304 38.441 60.1 220.49 
25% Novel 3 311.053 38.441 230.9 391.24 
50% Novel 3 276.588 38.441 196.4 356.78 
6% NaOCl 3 77.274 38.441  -2.9 157.46 
70% DMSO 3 308.330 38.441 228.1 388.52 
EDTA / DMSO 3 362.259 38.441 282.1 442.45 
EDTA/NaOCl 3 129.436 38.441 49.2 209.62 
EDTA/Novel 3 257.027 38.441 176.8 337.21 
No Treatment 3 17.547 38.441  -62.6 97.73 
Table 51:  Means for One-way ANOVA, Penetration Study 
Std Error uses a pooled estimate of error variance 
 
 
Confidence Quantile 
q* Alpha 
3.54111 0.05 
Table 52: Means Comparisons for all pairs using Tukey-Kramer HSD, Penetration Study  
 
 
Level             Mean Penetration 
(micrometers) 
100% Novel A          601.52033 
EDTA / DMSO   B        362.25867 
25% Novel   B C      311.05267 
70% DMSO   B C      308.33000 
50% Novel   B C      276.58767 
EDTA/Novel   B C D    257.02733 
17% EDTA     C D E  140.30367 
EDTA/NaOCl     C D E  129.43567 
6% NaOCl       D E  77.27400 
No Treatment         E  17.54667 
Table 53: Connecting Letters Report, Penetration Study  
Levels not connected by same letter are significantly different. 
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Level  - Level Difference Std Err Dif Lower CL Upper CL p-Value  
100% N T 583.9737 54.36436 391.464 776.4838 <.0001*  
100% 6% NaOCl 524.2463 54.36436 331.736 716.7565 <.0001*  
100% EDTA/NaOCl 472.0847 54.36436 279.575 664.5948 <.0001*  
100% 17% EDTA 461.2167 54.36436 268.707 653.7268 <.0001*  
E / D N T 344.7120 54.36436 152.202 537.2221 0.0001*  
100% EDTA/Novel 344.4930 54.36436 151.983 537.0031 0.0001*  
100% 50% Novel 324.9327 54.36436 132.423 517.4428 0.0003*  
25%  N T 293.5060 54.36436 100.996 486.0161 0.0009*  
100% 70% DMSO 293.1903 54.36436 100.680 485.7005 0.0009*  
70% D N T 290.7833 54.36436 98.273 483.2935 0.0010*  
100% 25% Novel 290.4677 54.36436 97.958 482.9778 0.0010*  
E / D 6% NaOCl 284.984 54.36436 92.475 477.4948 0.0013*  
50% N T 259.0410 54.36436 66.531 451.5511 0.0037*  
E / N N T 239.4807 54.36436 46.971 431.9908 0.0080*  
100% EDTA / DMSO 239.2617 54.36436 46.752 431.7718 0.0081*  
25% 6% NaOCl 233.7787 54.36436 41.269 426.2888 0.0101*  
E / D EDTA/NaOCl 232.8230 54.36436 40.313 425.3331 0.0105*  
70% D 6% NaOCl 231.0560 54.36436 38.546 423.5661 0.0112*  
E / D 17% EDTA 221.9550 54.36436 29.445 414.4651 0.0161*  
50% 6% NaOCl 199.3137 54.36436 6.804 391.8238 0.0387*  
25% EDTA/NaOCl 181.6170 54.36436  -10.893 374.1271 0.0746  
E / N 6% NaOCl 179.7533 54.36436  -12.757 372.2635 0.0797  
70% D EDTA/NaOCl 178.8943 54.36436  -13.616 371.4045 0.0822  
25%  17% EDTA 170.7490 54.36436  -21.761 363.2591 0.1095  
70% D 17% EDTA 168.0263 54.36436  -24.484 360.5365 0.1202  
50% EDTA/NaOCl 147.1520 54.36436  -45.358 339.6621 0.2354  
50% 17% EDTA 136.2840 54.36436  -56.226 328.7941 0.3216  
E / N EDTA/NaOCl 127.5917 54.36436  -64.918 320.1018 0.4035  
17% E N T 122.7570 54.36436  -69.753 315.2671 0.4533  
E / N 17% EDTA 116.7237 54.36436  -75.786 309.2338 0.5187  
E / 6% N T 111.8890 54.36436  -80.621 304.3991 0.5728  
E / D EDTA/Novel 105.2313 54.36436  -87.279 297.7415 0.6477  
E / D 50% Novel 85.6710 54.36436  -106.839 278.1811 0.8446  
EDTA 6% NaOCl 63.0297 54.36436  -129.480 255.5398 0.9708  
6% N T 59.7273 54.36436  -132.783 252.2375 0.9792  
25% EDTA/Novel 54.0253 54.36436  -138.485 246.5355 0.9893  
E / D 70% DMSO 53.9287 54.36436  -138.581 246.4388 0.9894  
E / 6% 6% NaOCl 52.1617 54.36436  -140.348 244.6718 0.9916  
70% D EDTA/Novel 51.3027 54.36436  -141.207 243.8128 0.9925  
E / D 25% Novel 51.2060 54.36436  -141.304 243.7161 0.9926  
25% 50% Novel 34.4650 54.36436  -158.045 226.9751 0.9996  
70% D 50% Novel 31.7423 54.36436  -160.768 224.2525 0.9998  
50% EDTA/Novel 19.5603 54.36436  -172.950 212.0705 1.0000  
EDTA EDTA/NaOCl 10.8680 54.36436  -181.642 203.3781 1.0000  
25% 70% DMSO 2.7227 54.36436  -189.787 195.2328 .  
Table 54:  Ordered Differences Report, Penetration Study 
Percentages (100, 50, 25) reflect concentration of Novel Irrigant 
NT = No Treatment (Positive Control) 
E/D = 17% EDTA followed by 70% DMSO 
E/N = 17% EDTA followed by 100% Novel 
E/6% = 17% EDTA followed by 6% NaOCl 
6%=6% NaOCl 
70% D = 70% DMSO 
 
